![Piperazine, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F499173-1-2-34-dimethoxyphenyl-ethyl-4-3-phenylpropyl-piperazine.webp&w=3840&q=75)
CAS 165377-43-5: Piperazine, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-
Formula:C23H32N2O2
InChI:InChI=1S/C23H32N2O2/c1-26-22-11-10-21(19-23(22)27-2)12-14-25-17-15-24(16-18-25)13-6-9-20-7-4-3-5-8-20/h3-5,7-8,10-11,19H,6,9,12-18H2,1-2H3
InChI key:InChIKey=UVSWWUWQVAQPJR-UHFFFAOYSA-N
SMILES:O(C)C1=C(OC)C=CC(CCN2CCN(CCCC3=CC=CC=C3)CC2)=C1
Synonyms:- Piperazine, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-
- 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine
- Cutamesine
- AGY 94806
Sort by
Found 2 products.
Cutamesine
CAS:Controlled ProductCutamesine is a sigma-1 agonist that was shown to upregulate the transcription of neurotrophic factors in vitro. It has been shown to increase levels of dopamine and acetylcholine, as well as reducing locomotor activity in rodents. Cutamesine also inhibits the mitochondrial membrane potential, which can help prevent neurodegenerative diseases such as Parkinson's Disease. In addition, cutamesine has been shown to have anti-inflammatory properties and may be an effective treatment for infectious diseases. Low-dose cutamesine was found to have no effect on cognition or memory in mice, making it a promising therapeutic option for older adults with cognitive impairment.Formula:C23H32N2O2Purity:Min. 95%Molecular weight:368.51 g/molPiperazine, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-
CAS:Formula:C23H32N2O2Purity:98+%Color and Shape:SolidMolecular weight:368.5124